Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 September, 2017 05:39 IST
Lupin gets USFDA approval for generic Vibra-Tabs tablet
Source: IRIS | 11 Sep, 2017, 02.52PM
Comments  |  Post Comment

Pharma Major Lupin announced that it has received final approval for its Doxycycline Hyclate Tablet USP, 100 mg from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer Inc.'s Vibra-Tabs, 100 mg.

Lupin's Doxycycline Hyclate Tablet USP, 100 mg is the AB rated generic equivalent of Pfizer Inc.'s Vibra-Tabs, 100 mg. It is indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.

Doxycycline Hyclate Tablet USP, 100 mg had US sales of USD 149.9 million (IMS MAT June 2017).

Shares of the company gained Rs 8.85, or 0.91%, to trade at Rs 977.00. The total volume of shares traded was 272,593 at the BSE (2.43 p.m., Monday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Zydus, Pharm Aid enters into pact for vaccine technology in Russia - 19-Sep-2017 14:40
SBI ties up with Google on UPI-based payments app-Tez - 19-Sep-2017 10:11
Nalco inks MoU to explore possibility of forming JVC - 19-Sep-2017 10:07
Glenmark Pharma gets USFDAs final nod for Desonide ointment - 19-Sep-2017 10:04
Mahindra Lifespace Developers enters into partnership with IFC - 19-Sep-2017 10:01
Infosys enters into 7-year partnership with CMA CGM Group - 19-Sep-2017 09:54
Vascon Engineers receives LoA worth Rs 2.35 bn - 18-Sep-2017 13:43
Punj Lloyd bags order worth Rs 1.2 bn from Govt. of India - 18-Sep-2017 12:13
Alkem Laboratories intimates of USFDA inspection at Baddi facility - 18-Sep-2017 10:45
Wipro selected as strategic partner for data center services by Innogy - 18-Sep-2017 10:35
Zydus arm gets USFDAs final nod for Oseltamivir powder - 18-Sep-2017 10:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer